Ocean Biomedical, Inc.


1.62 (USD) • At close May 20, 2024
Bedrijfsnaam Ocean Biomedical, Inc.
Symbool OCEA
Munteenheid USD
Prijs 1.62
Beurswaarde 56,131,458
Dividendpercentage 0%
52-weken bereik 0.52 - 12.08
Industrie Biotechnology
Sector Healthcare
CEO Ms. Elizabeth Ng M.B.A.
Website http://www.oceanbiomedical.com

An error occurred while fetching data.

Over Ocean Biomedical, Inc.

Ocean Biomedical, Inc., a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, infectious diseases, and inflammation. The company is developing mono-specific and bi-specific humanized monoclonal antibodies (mAb) product candidates targeting Chi3l1 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule

Vergelijkbare Aandelen

CF Bankshares Inc. logo

CF Bankshares Inc.


19.09 USD

Oconee Federal Financial Corp. logo

Oconee Federal Financial Corp.


12.82 USD

Franklin Financial Services Corporation logo

Franklin Financial Services Corporation


26.57 USD

Vision Sensing Acquisition Corp. logo

Vision Sensing Acquisition Corp.


11.55 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)